Your browser doesn't support javascript.
loading
Associations Between Multiple Measures of HIV-1 Persistence in Persons on Suppressive Antiretroviral Therapy.
Bosch, Ronald J; Gandhi, Rajesh T; Mar, Hanna; Eron, Joseph J; Cyktor, Joshua C; McMahon, Deborah K; Mellors, John W.
  • Bosch RJ; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
  • Gandhi RT; Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Mar H; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
  • Eron JJ; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Cyktor JC; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • McMahon DK; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Mellors JW; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
J Infect Dis ; 225(12): 2163-2166, 2022 06 15.
Article en En | MEDLINE | ID: mdl-35137129
Clinical research to achieve antiretroviral therapy-free remission requires quantitative assays of the HIV-1 reservoir. Intact proviral DNA (IPD) measurement has greater throughput than the quantitative viral outgrowth assay (QVOA). In 25 individuals with well-documented long-term viral suppression, IPD levels and infectious units per million CD4+ T cells by QVOA strongly correlated (r = 0.59, P = .002), and IPD correlated with total cell-associated HIV-1 DNA and cell-associated HIV-1 RNA (r = 0.62 and r = 0.59, P ≤ .002). IPD may provide an accessible marker of inducible replication-competent virus, total numbers of infected cells, and cellular expression of HIV-1 RNA.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article